RCEL
Avita Medical LtdNASDAQ
Healthcare • Medical Devices
Factor tilt: Small-Cap Blend
$16.59+5.80%
Close Nov 6, 2026
- Market cap
- $510.14M
- 1 month
- +24.5%
- 3 months
- +118.3%
- 1 year
- +374.0%
- 52-week range
- $3.27$16.71
- Dividend
- No dividends on record
- Next-quarter EPS estimate
- -$0.29Quarter to Sep 30, 2026 · 4 analysts · revenue $32.11M · -0.6% in 30d
- Short interest
- 9.3% of float2.8M shares · settled Oct 15, 2026 · -1.8% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $75.63M
- Net income
- -$43.08M
- Free cash flow
- -$23.59M
- Book value
- —
- Total debt
- $48.48M
- P/E
- —
- Price / sales
- 6.7×
- Price / book
- —
- FCF yield
- -4.6%
- Net margin
- -57.0%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Read more
It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
- Website
- avitamedical.com
- Headquarters
- Valencia, CA, United States
- Employees
- 226
- Listed
- Oct 1, 2019
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 22, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 6, 2026 | $21.7M | +17.8% | 81.9% | -$6.9M | -$7.7M |
| Mar 2026filed May 14, 2026 | $19.3M | +4.0% | 81.7% | -$8.8M | -$10.6M |
| Dec 2025filed Feb 12, 2026 | $17.6M | -4.3% | 81.2% | -$10.4M | -$11.6M |
| Sep 2025filed Nov 6, 2025 | $17.1M | -12.7% | 81.3% | -$9.2M | -$13.2M |
| Jun 2025filed Aug 8, 2025 | $18.4M | +21.2% | 81.2% | -$11.1M | -$9.9M |
| Mar 2025filed May 8, 2025 | $18.5M | +66.7% | 84.7% | -$11.8M | -$13.9M |
| Dec 2024filed Feb 13, 2025 | $18.4M | +29.7% | 87.6% | -$10.0M | -$11.6M |
| Sep 2024filed Nov 7, 2024 | $19.5M | — | 83.7% | -$13.8M | -$16.2M |
Fiscal years · last 3
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 12, 2026 | $71.6M | +11.5% | 82.1% | -$42.5M | -$48.6M |
| Dec 2024filed Feb 13, 2025 | $64.3M | +28.1% | 85.8% | -$56.6M | -$61.8M |
| Dec 2023filed Feb 22, 2024 | $50.1M | — | 84.5% | -$42.7M | -$35.4M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched RCEL. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
2,835,905 shares short
-52,076 shares (-1.8%) vs Sep 30, 2026
9.3% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,887,981 shares short
+2,288 shares (+0.1%) vs Sep 15, 2026
9.5% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,885,693 shares short
-52,336 shares (-1.8%) vs Aug 31, 2026
9.5% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
2,938,029 shares short
+189,451 shares (+6.9%) vs Aug 14, 2026
9.7% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
2,748,578 shares short
+141,107 shares (+5.4%) vs Jul 31, 2026
9% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
2,607,471 shares short
-9,715 shares (-0.4%) vs Jul 15, 2026
8.6% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind RCEL’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 5 · reverse split
Effective Jun 30, 2020
Each 5 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if RCEL is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
9 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 75 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 14
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
74 filers reported a long position in RCEL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
75.1%
of the 4.9M shares 13-F filers reported
Moves vs Q1 2026
5 added5 trimmed
Net shares held
-8.3%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | $5.5M · 1.3M shares | 1.3M | -0.1% |
| 2 | BlackRock, Inc. | $2.3M · 565K shares | 565K | -50.1% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $1.4M · 339.8K shares | 339.8K | -37.4% |
| 4 | MARSHALL WACE, LLP | $1.4M · 338.4K shares | 338.4K | +543.8% |
| 5 | AQR CAPITAL MANAGEMENT LLC | $1.3M · 321K shares | 321K | +240.2% |
| 6 | MORGAN STANLEY | $827.9K · 200.5K shares | 200.5K | +27.2% |
| 7 | VANGUARD FIDUCIARY TRUST CO | $753.3K · 182.4K shares | 182.4K | -5.7% |
| 8 | NewEdge Advisors, LLC | $615.1K · 148.9K shares | 148.9K | +71.4% |
| 9 | MACQUARIE GROUP LTD | $595.4K · 144.2K shares | 144.2K | +1,111.3% |
| 10 | STATE STREET CORP | $532.7K · 129K shares | 129K | -69.9% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inGet the Full Analysis for RCEL
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.